Skip to main content
Overview
About Us
Our Science
Pipeline
Clinical Trials
News Center
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Stock Information
Analyst Coverage
Financials & Filings
Overview
Quarterly Results
SEC Filings
Irish Statutory Financial Statements
Proxy Statements
Corporate Governance
Corporate Governance
Committee Composition
Executive Management
Board of Directors
Investor Resources
Investor Email Alerts
Careers
Contact us
Follow us
Overview
Why Invest
News
Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Investor Resources
Analyst Coverage
Stock Information
Analyst Coverage
Analyst Coverage table
Analyst
Firm
Phone
Tazeen Ahmad
Bank of America Merrill Lynch
(646) 855-4236
Charles C. Duncan, Ph.D.
Cantor Fitzgerald
(212) 915-1236
Rudy Li, Ph.D., CFA
Chardan
(646) 984-6221
Umer Raffat
Evercore ISI
(212) 888-3905
Andrew S. Fein
H.C. Wainwright
(212) 356-0546
Michael J. Yee
Jefferies
(415) 229-1535
Jason Butler
JMP Securities
(212) 906-3505
Jay Olson, CFA
Oppenheimer
(212) 667-8126
Yasmeen Rahimi, Ph.D.
Piper Sandler
(646) 819-3586
Brian Abrahams
RBC
(212) 858-7066
Prothena Corporation plc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Prothena Corporation plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Prothena Corporation plc or its management. Prothena Corporation plc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.